These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37957895)

  • 1. Natural history of Duchenne muscular dystrophy in the United Kingdom: A descriptive study using the Clinical Practice Research Datalink.
    Broomfield J; Abrams K; Latimer N; Guglieri M; Rutherford M; Crowther M
    Brain Behav; 2023 Dec; 13(12):e3331. PubMed ID: 37957895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review.
    Szabo SM; Salhany RM; Deighton A; Harwood M; Mah J; Gooch KL
    Orphanet J Rare Dis; 2021 May; 16(1):237. PubMed ID: 34022943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database.
    Koeks Z; Bladen CL; Salgado D; van Zwet E; Pogoryelova O; McMacken G; Monges S; Foncuberta ME; Kekou K; Kosma K; Dawkins H; Lamont L; Bellgard MI; Roy AJ; Chamova T; Guergueltcheva V; Chan S; Korngut L; Campbell C; Dai Y; Wang J; Barišić N; Brabec P; Lähdetie J; Walter MC; Schreiber-Katz O; Karcagi V; Garami M; Herczegfalvi A; Viswanathan V; Bayat F; Buccella F; Ferlini A; Kimura E; van den Bergen JC; Rodrigues M; Roxburgh R; Lusakowska A; Kostera-Pruszczyk A; Santos R; Neagu E; Artemieva S; Rasic VM; Vojinovic D; Posada M; Bloetzer C; Klein A; Díaz-Manera J; Gallardo E; Karaduman AA; Oznur T; Topaloğlu H; El Sherif R; Stringer A; Shatillo AV; Martin AS; Peay HL; Kirschner J; Flanigan KM; Straub V; Bushby K; Béroud C; Verschuuren JJ; Lochmüller H
    J Neuromuscul Dis; 2017; 4(4):293-306. PubMed ID: 29125504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic Evaluation in Duchenne Muscular Dystrophy: Model Frameworks for Cost-Effectiveness Analysis.
    Landfeldt E; Alfredsson L; Straub V; Lochmüller H; Bushby K; Lindgren P
    Pharmacoeconomics; 2017 Feb; 35(2):249-258. PubMed ID: 27798808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy.
    Bourke JP; Bueser T; Quinlivan R
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009068. PubMed ID: 30326162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review.
    Ryder S; Leadley RM; Armstrong N; Westwood M; de Kock S; Butt T; Jain M; Kleijnen J
    Orphanet J Rare Dis; 2017 Apr; 12(1):79. PubMed ID: 28446219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between timing of corticosteroid treatment initiation and clinical outcomes in Duchenne muscular dystrophy.
    Kim S; Zhu Y; Romitti PA; Fox DJ; Sheehan DW; Valdez R; Matthews D; Barber BJ;
    Neuromuscul Disord; 2017 Aug; 27(8):730-737. PubMed ID: 28645460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural history of the patients with Duchenne muscular dystrophy in Taiwan: A medical center experience.
    Liang WC; Wang CH; Chou PC; Chen WZ; Jong YJ
    Pediatr Neonatol; 2018 Apr; 59(2):176-183. PubMed ID: 28903883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life Expectancy in Duchenne Muscular Dystrophy: Reproduced Individual Patient Data Meta-analysis.
    Broomfield J; Hill M; Guglieri M; Crowther M; Abrams K
    Neurology; 2021 Dec; 97(23):e2304-e2314. PubMed ID: 34645707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroids for the treatment of Duchenne muscular dystrophy.
    Matthews E; Brassington R; Kuntzer T; Jichi F; Manzur AY
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD003725. PubMed ID: 27149418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing the Occurrence of Key Clinical Milestones in Duchenne Muscular Dystrophy in the United States Using Real-World Data.
    Szabo SM; Klimchak AC; Qian C; Iannaccone S; Popoff E; Gooch KL
    J Neuromuscul Dis; 2022; 9(6):689-699. PubMed ID: 36245384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health profile of a cohort of adults with Duchenne muscular dystrophy.
    Pandya S; James KA; Westfield C; Thomas S; Fox DJ; Ciafaloni E; Moxley RT
    Muscle Nerve; 2018 Aug; 58(2):219-223. PubMed ID: 29543994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy.
    Barber BJ; Andrews JG; Lu Z; West NA; Meaney FJ; Price ET; Gray A; Sheehan DW; Pandya S; Yang M; Cunniff C
    J Pediatr; 2013 Oct; 163(4):1080-4.e1. PubMed ID: 23866715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to diagnosis of Duchenne muscular dystrophy remains unchanged: Findings from the Muscular Dystrophy Surveillance, Tracking, and Research Network, 2000-2015.
    Thomas S; Conway KM; Fapo O; Street N; Mathews KD; Mann JR; Romitti PA; Soim A; Westfield C; Fox DJ; Ciafaloni E;
    Muscle Nerve; 2022 Aug; 66(2):193-197. PubMed ID: 35312090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions.
    Spurney CF
    Muscle Nerve; 2011 Jul; 44(1):8-19. PubMed ID: 21674516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends with corticosteroid use in males with Duchenne muscular dystrophy born 1982-2001.
    Fox DJ; Kumar A; West NA; DiRienzo AG; James KA; Oleszek J;
    J Child Neurol; 2015 Jan; 30(1):21-6. PubMed ID: 24682290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
    Manzur AY; Kuntzer T; Pike M; Swan A
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003725. PubMed ID: 18254031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractures and Linear Growth in a Nationwide Cohort of Boys With Duchenne Muscular Dystrophy With and Without Glucocorticoid Treatment: Results From the UK NorthStar Database.
    Joseph S; Wang C; Bushby K; Guglieri M; Horrocks I; Straub V; Ahmed SF; Wong SC;
    JAMA Neurol; 2019 Jun; 76(6):701-709. PubMed ID: 30855644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 in advanced Duchenne/Becker muscular dystrophy patients.
    Levine H; Prais D; Aharoni S; Nevo Y; Katz J; Rahmani E; Goldberg L; Scheuerman O
    Neuromuscul Disord; 2021 Jul; 31(7):607-611. PubMed ID: 34053847
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.